Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure-Reference-Cited by-同舟云学术

Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure

Published:2007-10 Issue:4 Volume:43 Page:388-403
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Gupta Mahesh P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference161 articles.

1. Functional changes in pathologic hypertrophy;Spann,1984

2. Cross-bridge dynamics in human ventricular myocardium. Regulation of contractility in the failing heart;Hajjar;Circulation,1992

3. Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium;Mann;Circ. Res.,1991

4. Left ventricular systolic resistance in rats with hypertension and hypertrophy;Shroff;Am. J. Physiol.: Heart Circ Physiol,1989

5. The cardiac myosin activator CK-1316719 increases myofibril ATPase activity and myocyte contractility in a rat model of heart failure;Anderson;Circulation,2006

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of Angiotensin II–Induced Cellular Hypertrophy by Cannflavin-C: Unveiling the Impact on Cytochrome P450 1B1 and Arachidonic Acid Metabolites;Drug Metabolism and Disposition;2024-06-05

2. UCP1‐dependent brown adipose activation accelerates cardiac metabolic remodeling and reduces initial hypertrophic and fibrotic responses to pathological stress;The FASEB Journal;2024-05-29

3. Sex-specific regulation of the cardiac transcriptome by the protein phosphatase 2A regulatory subunit B55α;2024-05-05

4. Analysis of age-related changes in the left ventricular myocardium with multiphoton microscopy;Biomedical Optics Express;2024-04-23

5. Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia;Biomedicines;2024-03-06